侵袭性分化甲状腺癌的新疗法

IF 1.2

International Journal of Endocrine Oncology Pub Date : 2018-02-01 DOI:10.2217/IJE-2017-0022

S. Donato, Rita Santos, H. Simões, V. Leite

引用次数: 5

摘要

Sara Donato1，Rita Santos1,2，Helder Simões1,2&Valeriano Leite*，1,2,3 1里斯本肿瘤研究所肿瘤系，Francisco Gentil，里斯本，葡萄牙2里斯本新里斯本大学医学院/医学院，Francisco Gentil，葡萄牙里斯本*通信作者：vleite@ipolisboa.min-saude.pt

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Novel therapies against aggressive differentiated thyroid carcinomas

Sara Donato1, Rita Santos1,2, Helder Simões1,2 & Valeriano Leite*,1,2,3 1Endocrinology Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal 2NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal 3Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal *Author for correspondence: vleite@ipolisboa.min-saude.pt

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Endocrine Oncology ONCOLOGY-

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： International Journal of Endocrine Oncology is a quarterly, peer-reviewed journal that helps the clinician to keep up to date with best practice in this fast-moving field. The journal highlights significant advances in basic and translational research, and places them in context for future therapy. The journal presents the latest research findings in diagnosis and management of endocrine cancer, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. The journal welcomes the unsolicited submission of article proposals and original research manuscripts.